This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Arcus Biosciences, Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovations of Karl T. Haelsig
Introduction
Karl T. Haelsig is a notable inventor based in Berkeley, California. He has made significant contributions to the field of chemistry, particularly in the development of compounds with therapeutic applications. With a total of four patents to his name, Haelsig's work is recognized for its potential impact on medical treatments.
Latest Patents
Haelsig's latest patents include a process for preparing tetralin compounds. This patent describes processes and intermediates useful for preparing specific compounds at multigram or kilogram scale. Another significant patent focuses on tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α. These compounds are described as having potential applications in treating various diseases, including cancer and immune-related disorders.
Career Highlights
Karl T. Haelsig is currently associated with Arcus Biosciences, Inc., where he continues to innovate and contribute to the field of biochemistry. His work is characterized by a commitment to developing compounds that can address critical health issues.
Collaborations
Haelsig collaborates with talented individuals such as Joel Worley Beatty and Samuel Lawrie Drew. These partnerships enhance the research and development efforts at Arcus Biosciences, Inc.
Conclusion
Karl T. Haelsig's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile